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Abstract
Background: To compare the effect of a sustained inflation followed by an incremental mean
airway pressure trial during conventional and high-frequency oscillatory ventilation on oxygenation
and hemodynamics in a large porcine model of early acute respiratory distress syndrome.
Methods: Severe lung injury (Ali) was induced in 18 healthy pigs (55.3 ± 3.9 kg, mean ± SD) by
repeated saline lung lavage until PaO2 decreased to less than 60 mmHg. After a stabilisation period
of 60 minutes, the animals were randomly assigned to two groups: Group 1 (Pressure controlled
ventilation; PCV): FIO2 = 1.0, PEEP = 5 cmH2O, VT = 6 ml/kg, respiratory rate = 30/min, I:E = 1:1;
group 2 (High-frequency oscillatory ventilation; HFOV): FIO2 = 1.0, Bias flow = 30 l/min, Amplitude
= 60 cmH2O, Frequency = 6 Hz, I:E = 1:1. A sustained inflation (SI; 50 cmH2O for 60s) followed by
an incremental mean airway pressure (mPaw) trial (steps of 3 cmH2O every 15 minutes) were
performed in both groups until PaO2 no longer increased. This was regarded as full lung inflation.
The mPaw was decreased by 3 cmH2O and the animals reached the end of the study protocol. Gas
exchange and hemodynamic data were collected at each step.
Results: The SI led to a significant improvement of the PaO2/FiO2-Index (HFOV: 200 ± 100 vs.
PCV: 58 ± 15 and TAli: 57 ± 12; p < 0.001) and PaCO2-reduction (HFOV: 42 ± 5 vs. PCV: 62 ± 13
and TAli: 55 ± 9; p < 0.001) during HFOV compared to lung injury and PCV. Augmentation of mPaw
improved gas exchange and pulmonary shunt fraction in both groups, but at a significant lower
mPaw in the HFOV treated animals. Cardiac output was continuously deteriorating during the
recruitment manoeuvre in both study groups (HFOV: TAli: 6.1 ± 1 vs. T75: 3.4 ± 0.4; PCV: TAli: 6.7
± 2.4 vs. T75: 4 ± 0.5; p < 0.001).
Conclusion: A sustained inflation followed by an incremental mean airway pressure trial in HFOV
improved oxygenation at a lower mPaw than during conventional lung protective ventilation.
HFOV but not PCV resulted in normocapnia, suggesting that during HFOV there are alternatives
to tidal ventilation to achieve CO2-elimination in an "open lung" approach.
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Current treatment goals in patients with acute respiratory
distress syndrome (ARDS) are to maintain adequate oxy-
genation while minimizing ventilator-associated lung
injury (VILI) [1,2]. Several experimental studies have
shown that mechanical ventilation (MV) can cause or per-
petuate lung injury if alveolar overdistension, repetitive
collapse and reopening of alveolar units occur [3,4].
Based on these findings, it is now recommended that
patients with ARDS should be ventilated with low tidal
volumes to limit end-inspiratory pressure and alveolar
overdistension, while maintaining the lung open with suf-
ficient positive end-exspiratory pressure (PEEP) to prevent
alveolar collapse [5,6]. Although this lung protective strat-
egy significantly reduces mortality in patients with ARDS,
it is recognized that low peak pressure ventilation favours
further lung derecruitment [7,8]. Recruitment manoeu-
vres (RM) composed of periodic sighs or sustained infla-
tions to reexpand the collapsed lung units have been
proposed as an adjunct to MV during general anaesthesia
and ARDS [9-11]. Such manoeuvres may lead to immedi-
ate improvements in respiratory compliance and oxygen-
ation. However, in clinical practice, many patients with
ARDS remain hypoxemic using conventional lung protec-
tive ventilatory approaches, and the morbidity and mor-
tality of patients suffering from ARDS remains
unacceptably high [5,6,12].
High-frequency oscillatory ventilation (HFOV) is an alter-
native to conventional lung protective ventilation. The
application of tidal volumes less than 6 ml/kg body
weight combined with a high mean airway pressure
(mPaw) to avoid lung overdistension and derecruitment,
provides a basis for an alternative lung protective ventila-
tory strategy [13,14]. In a multicenter randomized con-
trolled trial, Derdak and colleagues showed a significant
early improvement of the PaO2/FiO2-Ratio in the HFOV
group, while applying a significantly higher mPaw [15]. In
small animal studies of acute lung injury and neonatal
and paediatric respiratory distress syndrome, HFOV, uti-
lizing an aggressive lung recruiting strategy, was shown to
be safe and improved oxygenation compared to conven-
tional mechanical ventilation [16-18]. HFOV, as a rescue
therapy, is increasingly employed in intensive care
patients with severe ARDS who remain hypoxemic during
conventional ventilation.
The aim of this study was to evaluate the immediate effect
of a sustained inflation (SI = 50 cmH2O) followed by an
incremental and matched mean positive airway pressure
augmentation in a large porcine model of severe ARDS
with two different lung protective ventilation strategies
(low-tidal pressure controlled ventilation versus HFOV)
on gas exchange and hemodynamics. We hypothesized,
that HFOV will reverse hypoxia at a lower mPaw than con-
ventional lung protective ventilation, thereby aiming for a
more lung protective recruitment strategy.
Methods
The study was approved by the Laboratory Animal Care
and Use Committee of the District of Unterfranken, Ger-
many and conducted in compliance with the National
Institutes of Health guidelines for ethical animal research.
Animal preparation
Eighteen healthy female pigs (weight 55.3 ± 3.9 kg, mean
± SD), Pietrain breed, were fasted for 24 hours with free
water access. After intramuscular premedication with ket-
amin (10 mg/kg), xylazine hydrochloride (1 mg/kg) and
atropine (25 μg/kg) an intravenous line was obtained,
and anaesthesia was induced with 10 mg/kg thiopental.
All animals were positioned supine and orally intubated
with a cuffed 8.5-mm ID endotracheal tube with an addi-
tional side lumen (Rueschelit®, Ruesch, Kernen, Ger-
many). Anaesthesia and muscle relaxation were
maintained with continuous infusion of 5–10 mg/kg/h
thiopental, 0.01 mg/kg/h fentanyl and 0.1 mg/kg/h pan-
curonium throughout the experiment. Pressure controlled
ventilation (PCV) was adjusted with a PEEP of 5 cmH2O,
a tidal volume of 6 ml/kg, a respiratory rate (RR) of 30/
min and an inspiratory to exspiratory ratio (I:E) of 1:1.
The inspiratory oxygen fraction (FIO2) was kept at 1.0.
Continuous electrocardiography (Servomed®, Hellige,
Freiburg i. Br., Germany), pulsoxymetry, capnography
and distal tracheal pressure monitoring were performed. A
20-gauge arterial catheter (Vygon, Ecouen, France) and a
9.0-French introducer sheath (Arrow, Reading, PA, USA)
were inserted in the left carotid artery and in the right
internal jugular vein respectively by using real-time ultra-
sound guidance (SonoSite 180 Plus®, SonoSite Inc.,
Botell, WA, USA). A 7.5-French flow-directed pulmonary
artery catheter (831F75, Edwards Lifescience, Irvine, CA,
USA) was inserted under transduced pressure guidance.
The core temperature, as determined by the pulmonary
artery catheter, was maintained at 38.0° ± 0.5°C during
the experiment by using a heating pad. After a bolus of
500 ml colloid solution (Voluven 6% HES 130/0.4, Fre-
senius Kabi, Bad Homburg, Germany) prior the recruit-
ment manoeuvre a continuous infusion of 4–5 ml/kg/h
balanced electrolyte solution was administered for ade-
quate hydration.
Data acquisition
All hemodynamic data were taken in the supine position
referenced to atmospheric pressure at the mid-chest level.
Mean arterial pressure (MAP), mean pulmonary artery
pressure (MPAP), central venous pressure (CVP) and pul-
monary artery occlusion pressure (PCWP) were recorded
(Servomed®, Hellige, Freiburg i. Br., Germany). Heart rate
(HR) was traced by the electrocardiogram. Cardiac outputPage 2 of 9
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techniques and expressed as the mean of three consecu-
tive measurements (Explorer®, Edwards Lifescience,
Irvine, CA, USA), each consisting of a 10 ml bolus of ice-
cold saline into the right atrium randomly during the res-
piratory cycles. Blood samples were drawn from systemic
arterial and pulmonary arterial lines and were immedi-
ately analyzed for oxygen pressure (PO2), carbon dioxide
pressure (PCO2) and pH using standard blood gas elec-
trodes (ABL 505®, Radiometer, Bronshoj, Denmark). In
each sample, hemoglobin and oxygen saturation (SO2)
were measured using specific spectroscopy (OSM3®, Radi-
ometer, Copenhagen, Denmark). Arterial (CaO2), mixed
venous (CvO2) and pulmonary capillary (CCO2) oxygen
contents (ml/dl) were calculated using the standard for-
mula: Oxygen content = hemoglobin concentration ×
1.34 × (% O2 saturation/100) + PO2 × 0.0031. Oxygen
delivery (DO2) and consumption (VO2) were determined
using the conventional formulas DO2 = CO × CaO2 × 10
and VO2 = CO × (CaO2 - CvO2) × 10. The standard shunt
equation was used to calculate the amount of venous
admixture (Qs/Qt): (CCO2 - CaO2)/(CCO2 - CvO2). Mean
airway pressure was measured at the side lumen ending at
the tubes tip using an air filled pressure transducer
(PM8050®, Draeger, Luebeck, Germany) referenced to
atmospheric pressure. The oxygenation index was calcu-
lated using the following formula: OI = (FiO2 × mPaw ×
100)/PaO2[19].
Experimental protocol
After instrumentation the animals were stabilized for 30
min in the supine position and baseline measurements
(Tbaseline) were performed. Severe lung injury was induced
by bilateral pulmonary lavages with 30 ml/kg isotonic
saline (38°C), repeated every 10 minutes until PaO2
decreased to less than 60 mmHg and remained stable for
60 minutes with unchanged ventilatory parameters.
Recruitment manoeuvres and ventilator adjustment
After stabilisation post injury measurements (Tali) were
obtained and the animals were randomly assigned to the
following treatment groups (n = 9/group):
1. PCV: FIO2 = 1.0, PEEP = 5 cmH2O, VT = 6 ml/kg, RR =
30/min, I:E = 1:1
2. High-frequency oscillatory ventilation (HFOV): FIO2 =
1.0, Bias flow = 30 l/min, Amplitude = 60 cmH2O, Fre-
quency = 6 Hz, I:E = 1:1 (Sensor Medics 3100 B, Yorba
Linda, CA, USA)
A sustained inflation (SI) was applied by an exspiratory
hold for 60 s (PEEP 50 cmH2O) in the PCV group and
increasing the mean airway pressure (mPaw) to 50
cmH2O without oscillation for 60 s in the HFOV group. In
both groups, the mPaw was then adjusted 3 cmH2O
higher than after acute lung injury (TAli) and increased in
steps of 3 cmH2O until PaO2 no longer increased or began
to decline. This was regarded as full lung inflation or the
beginning of lung overdistension. Afterwards mPaw was
reduced by 3 cmH2O and the animals reached the end of
the study protocol [20]. A 15-min equilibration period
between each modification was followed by measure-
ments of hemodynamics, arterial blood gases and respira-
tory parameters. Intrinsic PEEP was measured during PCV
by means of an endexspiratory occlusion manoeuvre (5
secs) at each time point and was always less than 1
cmH2O. Pulmonary artery blood gases were measured at
following time points: TBaseline, TAli, T60 and T120. At the
end of the study the animals were killed using an intrave-
nous overdose of sodium thiopental and T61® (Intervet,
Unterschleissheim, Germany). The study protocol and
time course of the whole experiment is outlined in Fig. 1.
Statistical analysis
The data were tested for normal distribution using the
Kolmogorov-Smirnov test. Values are reported as mean ±
SD. The data were analyzed using SigmaStat for Windows,
version 2.03 (Systat Software Inc., Point Richmond, USA).
Two-way analysis of variance (ANOVA) for repeated
measurements was used for data analysis. Student-New-
man-Keuls post hoc test was used for comparison of sig-
nificant ANOVA results within and between the groups. P
values of less than 0.05 were considered significant.
Because of different numbers of animals during the time
points T90 to T150 no data were statistically analyzed.
Results
Detailed data regarding hemodynamics, gas exchange and
respiratory parameters are presented in tables 1 and 2.
PaO2-, OI-, PaCO2 and CO-changes during the experi-
mental period are displayed in figures 2, 3, 4, 5.
Lung injury
All animals survived the complete study period. Acute
lung injury was induced in all animals by means of
repeated saline lung lavages (18 ± 3) with significant
changes (p ≤ 0.05) in pHa, PaCO2, OI, PaO2/FiO2-Index,
VO2, SvO2, mPaw, PIP, MAP, CVP, MPAP, Qs/Qt – ratio
and CO: pHa decreased from 7.46 ± 0.08 to 7.35 ± 0.06,
PaCO2 increased from 39.8 ± 5.9 to 54.9 ± 11.8 mmHg,
OI increased from 1.7 ± 0.2 to 27.6 ± 8.5, PaO2/FiO2-
Index declined from 564 ± 41.9 to 57 ± 12.2 mmHg, VO2
increased from 174 ± 40.0 to 212 ± 61.5 ml/min./m2,
SvO2 decreased from 83 ± 5.0 to 61 ± 11.0 %, mPaw
increased from 9.5 ± 0.5 to 14.9 ± 1.3 cmH2O, PIP
increased from 14.1 ± 1.2 to 24.8 ± 2.6 cmH2O, MAP
increased from 73 ± 11 to 93 ± 10 mmHg, CVP increased
from 5 ± 2.3 to 7 ± 2.4 mmHg, MPAP increased from 18
± 3.8 to 36 ± 5.5 mmHg, Qs/Qt increased from 8 ± 4 to 53Page 3 of 9
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significant differences could be detected between the 2
groups for the parameters tested at time points TBaseline and
TAli (tables 1 and 2, fig. 2, 3, 4 and 5).
Pulmonary gas exchange
The SI and rising mPaw led to a significant improvement
of OI and PaO2/FiO2-ratio in the HFOV group compared
to TAli and the PCV group from T15 to T75 (p ≤ 0.001 vs. TAl-
iand PCV; fig. 2 and 3). However, in the PCV group the SI
was associated with a deterioration of OI and PaO2/FiO2-
Ratio at T15. With rising mPaw oxygenation in the PCV
group increased and was significantly improved at T60 and
T75 (p ≤ 0.001 vs. TAli; fig. 2 and 3). At T60 the SvO2 was sig-
nificantly improved in both groups when compared to TAli
without detectable significant differences between the
groups (p ≤ 0.05 vs. TAli; table 2). PaCO2 improved signif-
icantly in the HFOV group compared to TAli and the PCV
group (p ≤ 0.001; fig. 4). The PCV animals remained
hypercapnic with a PaCO2 greater 55 mmHg resulting in a
pH of less than 7.35 throughout the experiment (fig. 4).
Hemodynamics and oxygen delivery
HR and MAP showed a downward drift during the SI and
incremental mPaw trial in both groups, but it was not nec-
essary to stop the recruitment manoeuvre due to critical
hemodynamic compromise.
HR was significantly lower at T15 in the HFOV vs. the PCV
group and from T15 to T60 vs. TAli (table 1). MAP signifi-
cantly decreased at T60 in the HFOV animals and at T75 in
both groups compared to TAli (table 1). CVP and PCWP
showed a significant elevation in the HFOV group from
T15 to T75 compared to TAli and CVP was significantly
higher than in the PCV group during the same time course
(table 1). MPAP was significantly lower in both groups
compared to TAli and at T15 significantly lower in the
HFOV than PCV animals (table 1). CO was significantly
lower and continuously falling in the HFOV group (fig.
5). At T15 CO was significantly lower in the HFOV com-
pared to PCV group and from T45 to T75 CO was signifi-
cantly decreased compared to TAli in PCV animals (fig. 5).
Qs/Qt was at T60 significant lower in both groups com-
pared to injury and significant reduced in the HFOV ver-
sus PCV group (table 1).
Study protocol and time courseFigure 1
Study protocol and time course. FiO2 = fraction of inspired oxygen; PEEP = positive endexspiratory pressure; Vt = tidal 
volume; RR = respiratory rate; I:E = inspiratory:exspiratory-ratio; PCV = pressure controlled ventilation; HFOV = High-fre-
quency oscillatory ventilation; mPaw = mean pulmonary airway pressure; PaO2 = arterial oxygen pressurePage 4 of 9
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This study investigated the impact of a sustained inflation
followed by an incremental and matched mean airway
pressure trial during HFOV and conventional lung protec-
tive ventilation on gas exchange and hemodynamics. The
major findings of our study are: 1) Combination of HFOV
and SI with rising mPaw improved oxygenation and
resulted in a significant reduction of pulmonary shunt
fraction at a lower mPaw than during conventional lung
protective ventilation. 2) The SI and rising mPaw resulted
in normocapnia in the HFOV but not in the PCV group 3)
Both groups exhibited a continuously deterioration in car-
diac output with rising mPaw.
The treatment of severe hypoxemia in ARDS is highly
dependent on the recruitment and maintenance of lung
volume [21,22]. This is related to the dynamic reopening
of previously collapsed lung units by increasing transpul-
monary pressure. In order to assess gas exchange at com-
parable levels, we chose to perform a SI followed by
stepwise increases in mPaw, which was measured contin-
uously in the trachea using a pressure transducer fast
enough to detect pressure changes at 6 Hertz. In both
groups we used the same SI of 50 cmH2O for 60 seconds
and afterwards set the mPaw 3 cmH2O higher than after
lung injury. The PaO2/FiO2-Ratio increased and the OI
decreased significantly in the HFOV, but not in the PCV
group (fig. 2 and 3). Our findings are similar to those of
previous studies, showing that HFOV therapy is safe and
results in early improvements in oxygenation compared
to conventional ventilation. Since very small tidal vol-
umes are generated with HFOV, there is little tidal recruit-
ment of the injured lung, recruitment of lung volume
appears to be essential in this setting [18,23]. The
improvement in oxygenation seems to correspond with
increases in lung volume [24]. In the HFOV animals this
increase was presumably maintained after the SI resulting
in significant PaO2/FiO2 enhancement. The favourable
Table 1: Hemodynamic variables during recruitment manoeuvre.
Group T baseline TALI T15 T30 T45 T60
Number of PCV 9 9 9 9 9 9
animals HFOV 9 9 9 9 9 9
HR PCV 71 ± 18 85 ± 22 85 ± 18 76 ± 20 73 ± 24 73 ± 23
[/min] HFOV 66 ± 9 79 ± 6 67 ± 5*+ 63 ± 3* 62 ± 4* 64 ± 5*
MAP PCV 75 ± 13*** 93 ± 11 84 ± 17 86 ± 11 86 ± 10 86 ± 10
[mmHg] HFOV 71 ± 8*** 94 ± 9 87 ± 7 87 ± 5 85 ± 6 83 ± 7**
CVP PCV 4.9 ± 2.4*** 7.1 ± 2.3 7.6 ± 1.8 8.1 ± 1.8 8.6 ± 2.1** 9.4 ± 2.5***
[mmHg] HFOV 5.2 ± 2.2** 6.4 ± 2.5 9.7 ± 2.0***+ 10.4 ± 2.1***+ 10.7± 1.9***+ 11.9 ± 2.0***+
MPAP PCV 19 ± 5*** 37 ± 6 34 ± 5*** 31 ± 4*** 28 ± 4*** 30 ± 3***
[mmHg] HFOV 17 ± 2*** 34 ± 5 30 ± 6**+ 27 ± 4*** 29 ± 4*** 31 ± 4**
PCWP PCV 7.3 ± 2.9 8.7 ± 2.1 10.2 ± 2.0 10.0 ± 2.3 12.0 ± 3.0*** 12.6 ± 3.0***
[mmHg] HFOV 7.4 ± 1.6** 9.7 ± 3.7 12.2 ± 2.8** 13.0 ± 2.9***+ 12.8 ± 1.8*** 14.0 ± 1.9***
Qs/Qt PCV 0.09 ± 0.05*** 0.54 ± 0.10 0.31 ± 0.17 **
(ratio) HFOV 0.06 ± 0.01*** 0.52 ± 0.07 0.10 ± 0.04***+
Group T75 T90 T105 T120 T135 T150
Number of PCV 9 9 9 9 7 4
animals HFOV 9 8 7 3
HR PCV 71 ± 18 74 ± 18 80 ± 18 83 ± 19 92 ± 18 100 ± 16
[/min] HFOV 67 ± 8 77 ± 10 82 ± 13 97 ± 13
MAP PCV 83 ± 7* 79 ± 6 76 ± 10 75 ± 8 73 ± 9 77 ± 4
[mmHg] HFOV 78 ± 6*** 77 ± 8 80 ± 6 80 ± 5
CVP PCV 10.4 ± 2.4*** 11.1 ± 2.0 11.7 ± 2.1 12.7 ± 3.0 13.4 ± 2.3 14.5 ± 2.5
[mmHg] HFOV 12.8 ± 2.0***+ 13.1 ± 1.8 13.4 ± 2.6 14.7 ± 2.9
MPAP PCV 32 ± 3*** 33 ± 3 35 ± 4 37 ± 3 39 ± 5 41 ± 2
[mmHg] HFOV 32 ± 4* 35 ± 5 36 ± 4 37 ± 4
PCWP PCV 13.4 ± 2.1*** 13.6 ± 2.8 15.4 ± 3.1 17.3 ± 3.5 19.0 ± 2.7 19.3 ± 1.9
[mmHg] HFOV 15.9 ± 2.4***+ 16.4 ± 2.5 16.3 ± 3.3 18.0 ± 2.6
Qs/Qt PCV 0.06 ± 0.02
(ratio) HFOV 0.04 ± 0.02
Data are mean ± standard deviation; Two-way-ANOVA with repeated measurements (Student-Newman-Keuls post hoc test): * p < 0.05 vs. TAli; ** 
p < 0.01 vs. TAli; *** p < 0.001 vs. TAli; HFOV compared with PCV: + p < 0.01. PCV = pressure controlled ventilation; HFOV = High-frequency 
oscillatory ventilation; HR = heart rate; MAP = mean arterial pressure; CVP = central venous pressure; MPAP = mean pulmonary artery pressure; 
PCWP = pulmonary capillary wedge pressure; Qs/Qt = pulmonary shunt fraction.Page 5 of 9
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group because the applied PEEP was possibly not high
enough to maintain previously recruited lung areas open.
Bond and co-workers failed to show acute volume recruit-
ment after SI, even when PEEP was set above the critical
closing pressure of the lung during large tidal volume ven-
tilation [24]. In contrast, Foti et al. showed that volume
recruitment manoeuvres can improve oxygenation and
alveolar recruitment during conventional ventilation at
low PEEP levels [9]. It has been suggested that the col-
lapsed lung, in which low PEEP is being used, benefits
more from a RM than lungs already ventilated with high
PEEP [24,25]. In ARDS patients ventilated with low tidal
volumes, derecruitment was reversed by a reexpansion
manoeuvre or prevented by an adequate PEEP level [8].
In our study the stepwise rises in mPaw resulted in an
improved oxygenation in both groups. At matched mPaw,
HFOV resulted in a significant higher PaO2/FiO2-Ratio
and a lower OI (fig. 2 and 3).
We did not try to achieve normocapnia. Ventilatory set-
tings were fixed in both study groups. This resulted in
hypercapnia in the conventional ventilation and in nor-
mocapnia in the HFOV group. This is presumably the
result of a greater reduction in physiologic deadspace ratio
in the HFOV animals, which was again most probably a
result of a greater lung volume ensuring a better ventila-
tion/perfusion relationship after the SI. These data are in
contrast with recently published randomized controlled
trial without RM, since normocapnia was not achievable
with HFOV in human and experimental ARDS-trials
[15,26].
Hemodynamic effect
We detected changes in the hemodynamic status during
the RM compared to TAli. Because of the potential for
Table 2: Variables of Gas exchange during recruitment manoeuvre.
Group T baseline TALI T15 T30 T45 T60
Number of PCV 9 9 9 9 9 9
animals HFOV 9 9 9 9 9 9
pHa PCV 7.45 ± 0.06*** 7.32 ± 0.06 7.31 ± 0.06 7.33 ± 0.05 7.34 ± 0.06 7.34 ± 0.06
HFOV 7.48 ± 0.09*** 7.35 ± 0.04 7.43 ± 0.05*+ 7.45± 0.06**+ 7.45 ± 0.05**+ 7.44 ± 0.05*+
DO2 PCV 794 ± 312 781 ± 216 740 ± 145 722 ± 133 677 ± 114 644 ± 110
(ml/min/m2) HFOV 662 ± 157 724 ± 152 710 ± 105 677 ± 99 624 ± 117 547 ± 59*
VO2 PCV 184 ± 42* 221 ± 72 194 ± 44
(ml/min/m2) HFOV 165 ± 37* 204 ± 52 188 ± 24
SvO2 PCV 83 ± 6*** 60 ± 14 69 ± 10*
[%] HFOV 84 ± 3*** 62 ± 8 72 ± 5**
mPaw PCV 10 ± 1*** 15 ± 2 18 ± 2*** 20 ± 2*** 23 ± 2*** 26 ± 2***
[cmH2O] HFOV 9 ± 0*** 15 ± 1 18 ± 1*** 21 ± 1*** 24 ± 1*** 27 ± 1***
PIP PCV 15 ± 1*** 25 ± 3 27 ± 3*** 28 ± 3*** 30 ± 3*** 33 ± 3***
[cmH2O] HFOV 14 ± 1*** 25 ± 2 20 ± 1***+ 23 ± 1***+ 26 ± 1***+ 29 ± 1***+
Group T75 T90 T105 T120 T135 T150
Number of PCV 9 9 9 9 7 4
animals HFOV 9 8 7 3
pHa PCV 7.35 ± 0.06 7.35 ± 0.05 7.35 ± 0.05 7.33 ± 0.05 7.31 ± 0,06 7.30 ± 0,04
HFOV 7.43 ± 0.04*+ 7.41± 0.05 7.39 ± 0.04 7.38 ± 0.04
DO2 PCV 591 ± 71* 571 ± 68 551 ± 65 506 ± 73 494 ± 89 475 ± 74
(ml/min) HFOV 503 ± 71** 461 ± 72 478 ± 60 489 ± 92
VO2 PCV 183 ± 27
(ml/min) HFOV 194 ± 18
SvO2 PCV 70 ± 4
[%] HFOV 66 ± 9
mPaw PCV 28 ± 1*** 31 ± 2 34 ± 1 36 ± 2 37 ± 4 36 ± 2
[cmH2O] HFOV 29 ± 2*** 32 ± 3 33 ± 4 33 ± 1
PIP PCV 35 ± 2*** 38 ± 2 42 ± 3 43 ± 4 45 ± 6 45 ± 2
[cmH2O] HFOV 31 ± 2***+ 34 ± 3 35 ± 4 35 ± 1
Data are mean ± standard deviation; Two-way-ANOVA with repeated measurements (Student-Newman-Keuls post hoc test): * p < 0.05, ** p < 
0.01, *** p < 0.001 vs. TAli; HFOV compared with PCV: + p < 0.001. PCV = pressure controlled ventilation; HFOV = High-frequency oscillatory 
ventilation; DO2 = oxygen delivery; VO2 = oxygen consumption; SvO2 = mixed venous oxygen saturation; mPaw = mean pulmonary airway 
pressure; PIP = peak pulmonary airway pressure.Page 6 of 9
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SI and an incremental and not decremental mPaw trial.
The higher mPaw applied during both respiratory modes
was associated with an early and persistent decrease in
CO, a persistent increase in CVP and PCWP and a small
decrease in MAP. The reason for these changes was most
likely the sustained increase in intrathoracic pressure as
described in previous studies [15,27].
Cardiac output (CO)Figure 5
Cardiac output (CO). CO (mean ± SD) during recruit-
ment manoeuvre. PCV = pressure controlled ventilation; 
HFOV = High-frequency oscillatory ventilation. * p < 0.05, ** 
p < 0.01 and *** p < 0.001 vs. TAli; + p < 0.01 HFOV vs. PCV. 
(n = 9 until 75 min).
Oxygenation Index (OI)Figure 3
Oxygenation Index (OI). Oxygenation Index (mean ± SD) 
during recruitment manoeuvre. PCV = pressure controlled 
ventilation; HFOV = High-frequency oscillatory ventilation. * 
p < 0.001 vs. TAli; + p < 0.001 HFOV vs. PCV. (n = 9 until 75 
min).
PaO2/FiO2 – IndexFigure 2
PaO2/FiO2 – Index. PaO2/FiO2 – Index (mean ± SD) during 
recruitment manoeuvre. PCV = pressure controlled ventila-
tion; HFOV = High-frequency oscillatory ventilation. * p < 
0.001 vs. TAli; + p < 0.001 HFOV vs. PCV. (n = 9 until 75 
min).
Partial pressure of arterial carbon dioxide(PaCO2)Figure 4
Partial pressure of arterial carbon dioxide(PaCO2). 
PaCO2 (mean ± SD) during recruitment manoeuvre. PCV = 
pressure controlled ventilation; HFOV = High-frequency 
oscillatory ventilation. * p < 0.01 vs. TAli; + p < 0.01 HFOV 
vs. PCV. (n = 9 until 75 min).Page 7 of 9
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The major limitation of this study is that it was performed
in pigs and not in patients. In our study we used a sur-
factant-depletion lung-lavage model of ARDS. This model
does not represent the complexity of the lung injury in
ARDS patients. In addition, it is known that surfactant
depleted collapsed lungs respond better to PEEP applica-
tion and RM than lungs with alveolar flooding [25,28].
We used PaO2 as a surrogate marker for lung volume
recruitment, since lung volumes and pressure volume
relationships have not been directly quantified [29]. It
was shown recently, that generation of pressure volume
curves is associated with further lung derecruitment [30].
Additional deterioration of oxygenation in our animals
after lung injury would have implied a high risk of irre-
versible hypoxia.
Probably due to the severity of the experimentally
induced ARDS, the compliance changes in our model
were very consistent across the animals and linear
throughout the incremental mPaw-trial. This linearity
enabled us to increase mPaw in steps of 3 cmH2O in the
PCV-group by PEEP-augmentation of 3 cm H2O. The
results are not transferable to other animal models or
humans with lungs characterized by different pressure-
volume-relationships.
Conclusion
In this saline lavage induced large porcine model of early
severe ARDS, sustained inflations followed by an incre-
mental mean airway pressure trial improved gas exchange
and resulted in a significant reduction of pulmonary
shunt fraction at a lower mPaw during HFOV than during
conventional lung protective ventilation. Large animal
long term trials with acquisition of histopathologic and
inflammatory cytokine data are needed to evaluate
whether the thereby possible reduction of mPaw results in
further lung protection. Normocapnia was achieved in
HFOV but not in the PCV group, suggesting that large vol-
ume swings might not be required to eliminate CO2 in an
"open lung" approach.
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